Ledger.Open graph →

SEC Form D · filed September 7, 2021

Emulate, Inc

Offering

$57.5M

Sold

$57.5M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

BOSTON, MA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (30)

Aaron Vandevender · Boston, MADirector James Corbett · Boston, MAExec · Director Sharon Kedar · Boston, MADirector Martin Madaus · Boston, MADirector Franklin Witney · Boston, MADirector Eric Moessinger · Boston, MADirector Shlomo Melmed · Boston, MADirector Daniel Levner · Boston, MAExec · Director Linda Swenson · Smithfield, RIDirector David D. Williams · Smithfield, RIDirector Jonathan D. Sloane · Smithfield, RIExec · Director John Harwood · Smithfield, RIDirector Keith W. Sherin · Naples, FLExec · Director Chandler V. Jones · Brunswick, MEDirector Terri Burke · Louisville, CODirector Phil W. Roe · Franklin, TNDirector Donald Ingber · Boston, MADirector Larry Weiss · Boston, MAExec Scott Kantor · Boston, MAExec Mauricio Gruener · Miami, FLExec · Director Jeff Carron · Miami, FLDirector David H. Rowe · BOCA RATON, FLDirector Michael R. Greene · BOCA RATON, FLDirector Ben Calder · Austin, TXDirector William Ball · Austin, TXExec · Director Stephanie Culler · San Diego, CADirector Webster Equity Partners Iii-A GP, LLC · WALTHAM, MADirector Donald Ingber · Boston, MADirector Larry Weiss · Boston, MAExec Scott Kantor · Boston, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗